Weekly Clinical Updates

Respiratory Syncytial Virus-Associated Hospitalizations in Children <5 Years: 2016–2022 | Nirsevimab Effectiveness Against Cases of Respiratory Syncytial Virus Bronchiolitis Hospitalised in Paediatric Intensive Care Units in France, September 2023–January 2024 | Neurodevelopmental Delay in Children Exposed to Maternal SARS-CoV-2 In-utero | COVID-19 is Associated with Early Emergence of Preeclampsia: Results from a Large Regional Collaborative | Effectiveness of Nirmatrelvir/ritonavir in Children and Adolescents Aged 12–17 Years Following SARS-CoV-2 Omicron Infection: A Target Trial Emulation | Nirmatrelvir-Ritonavir and Symptoms in Adults with Postacute Sequelae of SARS-CoV-2 Infection The STOP-PASC Randomized Clinical Trial

CDC Confirms Second Human H5 Bird Flu Case in Michigan; Third Case Tied to Dairy Outbreak | Relative Efficacy of Masks and Respirators as Source Control for Viral Aerosol Shedding from People Infected with SARS-CoV-2: A Controlled Human Exhaled Breath Aerosol Experimental Study | Early Use of Oral Antiviral Drugs and the Risk of Post COVID-19 Syndrome: A Systematic Review and Network Meta-analysis | Long-COVID Autonomic Syndrome in Working Age and Work Ability Impairment

Antibodies to Influenza A(H5N1) Virus in Hunting Dogs | Cow’s Milk Containing Avian Influenza A(H5N1) Virus | Risk Factors for Pediatric Critical COVID-19 | The Risk of Aircraft-Acquired SARS-CoV-2 Transmission during Commercial Flights | Durability of XBB.1.5 Vaccines against Omicron Subvariants | Post-COVID Conditions Following COVID-19 Vaccination | The Importance of Including Long COVID Outcomes When Developing Novel Treatments for Acute COVID-19 | Cerebral Microstructural Alterations in Post-COVID-condition | Prevalence and Co-occurrence of Cognitive Impairment in Children | Long COVID Symptoms after 8-month Recovery

Estimates of SARS-CoV-2 Hospitalization and Fatality Rates in the Prevaccination Period | Characterization of Treatment Resistance and Viral Kinetics in the Setting of Single-Active Versus Dual-Active Monoclonal Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 | Cardiopulmonary Exercise Testing in Children with Long COVID | Assessment of the Impact of RNase in Patients With Severe Fatigue Related to Post-Acute Sequelae of SARS-CoV-2 Infection (PASC) | Potential Diaphragm Muscle Weakness-related Dyspnea Persists Two Years after COVID-19

Virome Sequencing Identifies H5N1 Avian Influenza in Wastewater from Nine Cities | COVID-19 Vaccines and Adverse Events of Special Interest: A Multinational Global Vaccine Data Network (GVDN) Cohort Study of 99 million Vaccinated Individuals | The Role of Colchicine in the Management of COVID-19: A Meta-analysis | Psychometric Analysis of the Modified COVID-19 Yorkshire Rehabilitation Scale (C19-YRSm) in a Prospective Multicentre Study

Favorable Antiviral Effect of Metformin on Severe Acute Respiratory Syndrome Coronavirus 2 | Association of Nirmatrelvir–ritonavir with Post-acute Sequelae and Mortality in Patients | Effectiveness of Nirmatrelvir-Ritonavir for the Prevention of COVID-19–Related Hospitalization | Cognitive Profile in Multiple Sclerosis and Post-COVID Condition | Unravelling the Mechanisms Behind Exercise Intolerance and Recovery in Long COVID | Epidemiology of SARS-CoV-2 in Kakuma Refugee Camp Complex, Kenya, 2020-2021